These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16273004)

  • 1. [Second-line treatment of advanced non-small-cell lung cancer: role of pemetrexed].
    Pérol M
    Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S14-7. PubMed ID: 16273004
    [No Abstract]   [Full Text] [Related]  

  • 2. Pemetrexed and maintenance therapy for non-small cell lung cancer.
    Prescrire Int; 2011 Feb; 20(113):39. PubMed ID: 21488588
    [No Abstract]   [Full Text] [Related]  

  • 3. Pemetrexed in advanced non-small-cell lung cancer.
    Fuld AD; Dragnev KH; Rigas JR
    Expert Opin Pharmacother; 2010 Jun; 11(8):1387-402. PubMed ID: 20446853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Update of pemetrexed in thoracic oncology].
    Brechot JM; Morère JF
    Bull Cancer; 2007; 94 Spec No Actualites():S139-41. PubMed ID: 17845984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancer.
    Sun JM; Lee KW; Kim JH; Kim YJ; Yoon HI; Lee JH; Lee CT; Lee JS
    Jpn J Clin Oncol; 2009 Jan; 39(1):27-32. PubMed ID: 18952704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study.
    Bearz A; Garassino I; Cavina R; Favaretto A; Boccalon M; Talamini R; Berretta M; Spazzapan S; Simonelli C; Santoro A; Tirelli U
    Lung Cancer; 2008 May; 60(2):240-5. PubMed ID: 18022729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pemetrexed for the treatment of non-small-cell lung cancer.
    Manegold C; Schmid-Bindert G; Pilz LR
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1195-209. PubMed ID: 19761423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of pemetrexed as maintenance treatment in advanced NSCLC: a Phase III randomized trial.
    Gridelli C; Di Maio M
    Expert Opin Pharmacother; 2010 Feb; 11(2):321-4. PubMed ID: 20053140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pemetrexed: new indication. Untreated non-small cell lung cancer: just another cytotoxic drug. No better than the gemcitabine-cisplatin combination with a different safety profile, as is the case for other cytotoxic drugs.
    Prescrire Int; 2009 Jun; 18(101):114. PubMed ID: 19637425
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of use of pemetrexed in non-small cell lung cancer].
    Villanueva-Herraiz S; Ortega-García MP; Camps-Herrero C; Blasco-Segura P
    Farm Hosp; 2010; 34(4):194-203. PubMed ID: 20594885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of pemetrexed in non-small cell lung cancer.
    Longo-Sorbello GS; Chen B; Budak-Alpdogan T; Bertino JR
    Cancer Invest; 2007 Feb; 25(1):59-66. PubMed ID: 17364559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of pemetrexed given with radiotherapy].
    Mornex F
    Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S18-9. PubMed ID: 16273005
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pemetrexed: from preclinic to clinic].
    Lansiaux A; Lokiec F
    Bull Cancer; 2007; 94 Spec No Actualites():S134-8. PubMed ID: 17845983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pemetrexed in the treatment of thoracic malignancies: a single centre experience in Singapore.
    Lopes G; Chopra A; Kukutschka J; Portillo P; Bharwani L; Chang A
    Singapore Med J; 2011 Mar; 52(3):190-4. PubMed ID: 21451928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated clinical information on multitargeted antifolates in lung cancer.
    Scagliotti GV; Ceppi P; Capelletto E; Novello S
    Clin Lung Cancer; 2009 Mar; 10 Suppl 1():S35-40. PubMed ID: 19362945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pemetrexed in first-line treatment of non-small cell lung cancer.
    Esteban E; Casillas M; Cassinello A
    Cancer Treat Rev; 2009 Jun; 35(4):364-73. PubMed ID: 19269106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of a promising new agent--pemetrexed disodium.
    Paz-Ares L; Bezares S; Tabernero JM; Castellanos D; Cortes-Funes H
    Cancer; 2003 Apr; 97(8 Suppl):2056-63. PubMed ID: 12673697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Safety of pemetrexed mono-therapy in elderly patients with non-small cell lung cancer].
    Konishi A; Kitada N; Nanjo S; Tanaka S; Tomii K; Katakami N; Hashida T
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1507-10. PubMed ID: 23064061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pemetrexed: a multitargeted antifolate.
    Rollins KD; Lindley C
    Clin Ther; 2005 Sep; 27(9):1343-82. PubMed ID: 16291410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pemetrexed development in oncology].
    Chaigneau L; Villanueva C; Thierry-Vuillemin A; Legat-Fagnoni C; N'Guyen T; Maurina T; Lorgis V; Pivot X
    Bull Cancer; 2007; 94 Spec No Actualites():S142-8. PubMed ID: 17845985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.